UNSPSC 51381503: Floctafenine

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C20H17F3N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O04HVX6A9Q, chemically known as 2,3-dihydroxypropyl n-(8-(trifluoromethyl)-4-quinolyl)anthranilate but generally known as floctafenine, which bears US NIH Compound Identifier 3360. European Medicines Agency schedules Floctafenine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07645MIG.

UNSPSC 51381503 Floctafenine is a Commodity code that covers pharmaceutical products, though the recent state and local procurement activity tracked under this code does not align with floctafenine itself. Instead, Seminole County, Florida issued an IFB in June 2026 for naloxone and safe drug deactivation systems, products outside the nominal scope of this code. The mismatch suggests either a tagging error in the procurement database or that this code is not the primary taxonomy vehicle for pharmaceutical procurement in state and local contracting.

The available record shows Seminole County, Florida seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through IFB60459723LAS, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The notice specified electronic bid submission, inclusion of all shipping and delivery costs, a two-year initial term with one-year renewal option, and standard compliance requirements including drug-free workplace certification and E-Verify. The solicitation indicates potential FEMA funding with associated federal compliance obligations. Because this single opportunity does not represent genuine recent activity under the floctafenine code itself, pursue this code with caution — the data signal is too weak to support reliable business development strategy.